{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:10Z","timestamp":1792790590626,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Rogel Scholar Award University of Michigan","id":[{"id":"https:\/\/ror.org\/00jmfr291","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41375-024-02448-8","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:02:03Z","timestamp":1729857723000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"39","author":[{"given":"Qiangqiang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2194-0128","authenticated-orcid":false,"given":"Jedrzej","family":"Wykretowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-3287","authenticated-orcid":false,"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1395-487X","authenticated-orcid":false,"given":"Isabella A.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-5612","authenticated-orcid":false,"given":"Surinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerby","family":"Shedden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-2449","authenticated-orcid":false,"given":"David","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7734-4387","authenticated-orcid":false,"given":"Sami N.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"2448_CR1","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2000","unstructured":"Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910\u20136.","journal-title":"N Engl J Med"},{"key":"2448_CR2","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515\u201325.","journal-title":"J Clin Invest"},{"key":"2448_CR3","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/sj.leu.2400819","volume":"11","author":"JR Neilson","year":"1997","unstructured":"Neilson JR, Auer R, White D, Bienz N, Waters JJ, Whittaker JA, et al. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia. 1997;11:1929\u201332.","journal-title":"Leukemia"},{"key":"2448_CR4","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated IgV(H. genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848\u201354.","journal-title":"Blood"},{"key":"2448_CR5","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840\u20137.","journal-title":"Blood"},{"key":"2448_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl J Med. 2004;351:893\u2013901.","journal-title":"N. Engl J Med"},{"key":"2448_CR7","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","volume":"118","author":"P Ouillette","year":"2011","unstructured":"Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, et al. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia. Blood. 2011;118:3051\u201361.","journal-title":"Blood"},{"key":"2448_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525\u201330.","journal-title":"Nature"},{"key":"2448_CR9","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/onc.2012.411","volume":"32","author":"SN Malek","year":"2013","unstructured":"Malek SN. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia. Oncogene. 2013;32:2805\u201317.","journal-title":"Oncogene"},{"key":"2448_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-4614-8051-8_9","volume":"792","author":"S Malek","year":"2013","unstructured":"Malek S. Molecular biomarkers in chronic lymphocytic leukemia. Adv Exp Med Biol. 2013;792:193\u2013214.","journal-title":"Adv Exp Med Biol"},{"key":"2448_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","volume":"85","author":"H Dohner","year":"1995","unstructured":"Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood. 1995;85:1580\u20139.","journal-title":"Blood"},{"key":"2448_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","volume":"9","author":"Z Gu","year":"2019","unstructured":"Gu Z, Liu Y, Cai F, Patrick M, Zmajkovic J, Cao H, et al. Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation. Cancer Discov. 2019;9:1228\u201347.","journal-title":"Cancer Discov"},{"key":"2448_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","volume":"175","author":"SK McBrayer","year":"2018","unstructured":"McBrayer SK, Mayers JR, DiNatale GJ, Shi DD, Khanal J, Chakraborty AA, et al. Transaminase inhibition by 2-Hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in Glioma. Cell. 2018;175:101\u2013116 e125.","journal-title":"Cell"},{"key":"2448_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S Raffel","year":"2017","unstructured":"Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, Lutz C, et al. BCAT1 restricts alphaKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature. 2017;551:384\u20138.","journal-title":"Nature"},{"key":"2448_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500\u20134.","journal-title":"Nature"},{"key":"2448_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm.3217","volume":"19","author":"M Tonjes","year":"2013","unstructured":"Tonjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med. 2013;19:901\u20138.","journal-title":"Nat Med"},{"key":"2448_CR17","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1158\/1078-0432.CCR-11-0785","volume":"17","author":"P Ouillette","year":"2011","unstructured":"Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K, et al. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res. 2011;17:6778\u201390.","journal-title":"Clin Cancer Res"},{"key":"2448_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/leu.2008.21","volume":"22","author":"A Poggi","year":"2008","unstructured":"Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR. Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia. 2008;22:980\u20138.","journal-title":"Leukemia"},{"key":"2448_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cmet.2018.08.013","volume":"29","author":"SM Son","year":"2019","unstructured":"Son SM, Park SJ, Lee H, Siddiqi F, Lee JE, Menzies FM, et al. Leucine signals to MTORC1 via Its metabolite acetyl-coenzyme A. Cell Metab. 2019;29:192\u2013201 e197.","journal-title":"Cell Metab"},{"issue":"6218","key":"2448_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1259472","volume":"347","author":"JL Jewell","year":"2015","unstructured":"Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW. et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science. 2015;347(6218):194\u20138. https:\/\/doi.org\/10.1126\/science.1259472.","journal-title":"Science"},{"key":"2448_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.molcel.2012.05.043","volume":"47","author":"RV Duran","year":"2012","unstructured":"Duran RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E, et al. Glutaminolysis activates Rag-MTORC1 signaling. Mol cell. 2012;47:349\u201358.","journal-title":"Mol cell"},{"issue":"5882","key":"2448_CR22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L. et al. The Rag GTPases bind raptor and mediate amino acid signaling to MTORC1. Science. 2008;320(5882):1496\u2013501. https:\/\/doi.org\/10.1126\/science.1157535.","journal-title":"Science"},{"key":"2448_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood.2021013990","volume":"140","author":"Z Chen","year":"2022","unstructured":"Chen Z, Simon-Molas H, Cretenet G, Valle-Argos B, Smith LD, Forconi F, et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 2022;140:630\u201343.","journal-title":"Blood"},{"key":"2448_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s43018-021-00216-6","volume":"2","author":"J Lu","year":"2021","unstructured":"Lu J, Cannizzaro E, Meier-Abt F, Scheinost S, Bruch PM, Giles HA, et al. Multi-omics reveals clinically relevant proliferative drive associated with MTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia. Nat Cancer. 2021;2:853\u201364.","journal-title":"Nat Cancer"},{"key":"2448_CR25","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1158\/1078-0432.CCR-10-2058","volume":"17","author":"K Saiya-Cork","year":"2011","unstructured":"Saiya-Cork K, Collins R, Parkin B, Ouillette P, Kuizon E, Kujawski L, et al. A pathobiological role of the insulin receptor in chronic lymphocytic leukemia. Clin Cancer Res. 2011;17:2679\u201392.","journal-title":"Clin Cancer Res"},{"key":"2448_CR26","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.18632\/aging.102001","volume":"11","author":"EE Baracco","year":"2019","unstructured":"Baracco EE, Castoldi F, Durand S, Enot DP, Tadic J, Kainz K, et al. alpha-Ketoglutarate inhibits autophagy. Aging. 2019;11:3418\u201331.","journal-title":"Aging"},{"key":"2448_CR27","doi-asserted-by":"crossref","unstructured":"Hillier J, Allcott GJ, Guest LA, Heaselgrave W, Tonks A, Conway ME, et al. The BCAT1 CXXC motif provides protection against ROS in Acute Myeloid Leukaemia Cells. Antioxidants 2022;11:683.","DOI":"10.3390\/antiox11040683"},{"key":"2448_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111524","volume":"41","author":"L Francois","year":"2022","unstructured":"Francois L, Boskovic P, Knerr J, He W, Sigismondo G, Schwan C, et al. BCAT1 redox function maintains mitotic fidelity. Cell Rep. 2022;41:111524.","journal-title":"Cell Rep"},{"key":"2448_CR29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1182\/blood-2007-07-099432","volume":"112","author":"L Kujawski","year":"2008","unstructured":"Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M, et al. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia. Blood. 2008;112:1993\u20132003.","journal-title":"Blood"},{"key":"2448_CR30","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1172\/JCI98288","volume":"129","author":"F Wang","year":"2019","unstructured":"Wang F, Gatica D, Ying ZX, Peterson LF, Kim P, Bernard D, et al. Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and MTOR. J Clin Invest. 2019;129:1626\u201340.","journal-title":"J Clin Invest"}],"updated-by":[{"DOI":"10.1038\/s41375-024-02472-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02448-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:04:38Z","timestamp":1736402678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02448-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1038\/s41375-024-02448-8","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article the affiliation details for Karan Bedi were incorrectly given as \u2018Computational Biology, University of Michigan\u2019 but should have been \u2018Biostatistics, University of Michigan\u2019. The original article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41375-024-02472-8","URL":"https:\/\/doi.org\/10.1038\/s41375-024-02472-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sami Malek owns stock in Abbvie. The other authors declared no conflicts.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}